CYLLENE Trademark

Trademark Overview


On Thursday, January 13, 2022, a trademark application was filed for CYLLENE with the United States Patent and Trademark Office. The USPTO has given the CYLLENE trademark a serial number of 97217701. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 15, 2024. This trademark is owned by Cellarity, Inc.. The CYLLENE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical agents, therapeutics and preparations for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders; pharmaceutical compositions in the nature of chemical small molecules for treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders

Diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases

Bioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; drug discovery services; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations
cyllene

General Information


Serial Number97217701
Word MarkCYLLENE
Filing DateThursday, January 13, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesPharmaceutical agents, therapeutics and preparations for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders; pharmaceutical compositions in the nature of chemical small molecules for treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders
Goods and ServicesDiagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases
Goods and ServicesBioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; drug discovery services; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, March 4, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, March 4, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellarity, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Party NameCellarity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Trademark Events


Event DateEvent Description
Tuesday, January 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 5, 2022NON-FINAL ACTION E-MAILED
Monday, December 5, 2022NON-FINAL ACTION WRITTEN
Thursday, October 20, 2022ASSIGNED TO EXAMINER
Thursday, January 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED